2019. NEOADJUVANT FOR PATIENTS WITH HIGH AND VERY HIGH RISK PROSTATE CANCER. Voprosy onkologii. 65, 5 (May 2019), 726–735. DOI:https://doi.org/10.37469/0507-3758-2019-65-5-726-735.